Evidence map›Paper›PMID 37047226›Full record

ReviewInternational journal of molecular sciences2023

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?

Manon Barthe, Leslie Hertereau, Noura Lamghari, Hanan Osman-Ponchet, Véronique M Braud

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Skin as a Potential Entry Point for SARS-CoV-2 Virus.International journal of molecular sciences · 2026
    Article
  3. SKIN AS A POTENTIAL ENTRY POINT FOR SARS-COV-2.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Manon BartheInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, CNRS UMR7275, 06560 Valbonne, France.
Leslie HertereauInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, CNRS UMR7275, 06560 Valbonne, France.
Noura LamghariInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, CNRS UMR7275, 06560 Valbonne, France.
Hanan Osman-PonchetPKDERM Laboratories, 45 Boulevard Marcel Pagnol, 06130 Grasse, France.
Véronique M BraudInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, CNRS UMR7275, 06560 Valbonne, France.ORCID 0000-0001-8213-3947
Centre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-21-CE34-0016Agence Nationale de la Recherche "Investments for the Future" programs LABEX SIGNALIFE ANR-11-LABX-0028 and IDEX UCAJedi ANR-15-IDEX-01,Association Nationale de la Recherche et de la Technologie CIFRE PhD grant N°2020/0804
6 · The paper itself

Abstract

To prevent the spread of SARS-CoV-2, all routes of entry of the virus into the host must be mapped. The skin is in contact with the external environment and thus may be an alternative route of entry to transmission via the upper respiratory tract. SARS-CoV-2 cell entry is primarily dependent on ACE2 and the proteases TMPRSS2 or cathepsin L but other cofactors and attachment receptors have been identified that may play a more important role in specific tissues such as the skin. The continued emergence of new variants may also alter the tropism of the virus. In this review, we summarize current knowledge on these receptors and cofactors, their expression profile, factors modulating their expression and their role in facilitating SARS-CoV-2 infection. We discuss their expression in the skin and their possible involvement in percutaneous infection since the presence of the virus has been detected in the skin.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2HumansPeptide HydrolasesSkinVirus InternalizationAngiotensin-Converting Enzyme 2Peptide HydrolasesACE2ASGR1AXLcathepsin LCD147furinKREMEN1NRP1SARS-CoV-2skinTMPRSS2

Identifiers

PMID37047226
PMCPMC10094153
OpenAlexW4361007161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.